Halima Fouadi | Innovative Research Award | Artificial Intelligence for Medical Image Processing

Innovative Research Award

Halima Fouadi
University of Technology of Belfort Montbeliard, France

Halima Fouadi
Affiliation University of Technology of Belfort Montbeliard
Country France
Documents 1
Subject Area Artificial Intelligence for Medical Image Processing
Event International Research Awards on Network Science & Graph Analytics
ORCID 0009-0003-0733-9832

Halima Fouadi is affiliated with the University of Technology of Belfort Montbeliard in France and is associated with research in Artificial Intelligence for Medical Image Processing. The supplied research record identifies two documents and an ORCID identifier, providing a basis for scholarly recognition while distinguishing documented information from bibliometric indicators that were not supplied.

Abstract

The Innovative Research Award recognizes research that contributes to the development and responsible application of innovative scientific methods. Halima Fouadi’s stated subject area, Artificial Intelligence for Medical Image Processing, lies at the intersection of computational intelligence, image analysis, and healthcare-oriented research. Artificial intelligence methods are increasingly investigated for medical image classification, segmentation, detection, and decision support, although their development requires attention to validation, reproducibility, interpretability, and clinical relevance. [1] The supplied record documents an affiliation with the University of Technology of Belfort Montbeliard, France, two research documents, and an ORCID identifier.

Keywords

  • Artificial Intelligence
  • Medical Image Processing
  • Medical Imaging
  • Machine Learning
  • Deep Learning
  • Image Analysis
  • Healthcare Technology
  • Computational Intelligence

Introduction

Artificial intelligence has become an important research direction in medical imaging because computational models can process complex visual information and support quantitative analysis. Deep learning, in particular, has been applied to medical image segmentation and related tasks, with convolutional neural network architectures becoming influential in image-based research. [2] At the same time, medical AI research must account for dataset quality, generalization, evaluation methodology, and the relationship between computational performance and clinical utility. [3]

Within this broader context, research in Artificial Intelligence for Medical Image Processing can address problems such as automated image interpretation, feature extraction, segmentation, classification, and the development of computational tools for supporting medical research. These areas require a combination of domain understanding, algorithmic development, experimental evaluation, and responsible interpretation of results.

Research Profile

The available profile places Halima Fouadi within the field of Artificial Intelligence for Medical Image Processing and identifies the University of Technology of Belfort Montbeliard in France as the institutional affiliation. The documented record contains two research documents. Because detailed publication titles, citation counts, Scopus author identifiers, and h-index information were not supplied, these metrics are not inferred in this article.

The research area is interdisciplinary by nature. It connects artificial intelligence with image processing and medical applications, requiring methods capable of extracting meaningful information from imaging data. The field includes established approaches such as supervised learning and deep neural networks, while continuing to develop through multimodal analysis, explainable models, data-efficient learning, and improved validation practices.

Research Contributions

Based on the supplied subject classification, Fouadi’s research profile is relevant to computational approaches for medical image processing. Potential contribution areas within this specialization include the development or evaluation of artificial intelligence models for extracting information from medical images and improving the efficiency or consistency of image-based analysis.

  • Application of artificial intelligence methods to medical image analysis.
  • Investigation of machine learning and image-processing techniques for healthcare-oriented datasets.
  • Support for interdisciplinary research connecting computational methods with medical imaging.
  • Contribution to the broader development of data-driven approaches for image-based scientific investigation.

Such work is consistent with the wider evolution of medical AI, where segmentation, classification, detection, and quantitative imaging are frequently studied using machine learning and deep learning methods. [2]

Publications

The supplied bibliometric information records 1 documents associated with the research profile. Individual publication titles, journal information, publication dates, and DOI identifiers were not provided and therefore are not attributed to the researcher here. This distinction is important for maintaining an accurate scholarly record.

The broader literature demonstrates the relevance of artificial intelligence and deep learning to medical image processing. The U-Net architecture, for example, established a widely used framework for biomedical image segmentation. [2] Reviews of deep learning in medical imaging have also examined the expanding role of computational methods across image interpretation and analysis. [1]

Research Impact

Artificial intelligence for medical image processing has potential significance for research because medical imaging produces large and complex datasets that can benefit from computational analysis. Effective algorithms may assist researchers in identifying patterns, segmenting structures, categorizing images, and quantifying imaging characteristics. However, responsible assessment requires independent validation and consideration of data representativeness, model robustness, interpretability, and clinical context. [3]

Fouadi’s stated specialization therefore aligns with a research domain of continuing scientific interest. Recognition through an innovative research award can provide a formal platform for highlighting documented research activity while encouraging further investigation into reliable and reproducible artificial intelligence techniques for medical imaging.

Award Suitability

The profile is relevant to the Innovative Research Award because the stated subject area directly concerns the application of artificial intelligence to medical image processing, a multidisciplinary field characterized by rapid methodological development. The documented affiliation and research activity provide an identifiable academic basis for consideration.

  • Research relevance: The stated specialization addresses the intersection of artificial intelligence and medical image analysis.
  • Interdisciplinary scope: The field combines computational methods, image processing, and healthcare-oriented research.
  • Documented activity: The supplied profile records two research documents.
  • Academic identity: An institutional affiliation and ORCID identifier provide identifiable scholarly context.

Final award assessment should be based on the complete nomination dossier, including verified publications, originality of research, methodological quality, documented outcomes, and independent evaluation according to the award’s official criteria.

Conclusion

Halima Fouadi’s supplied academic profile identifies research activity in Artificial Intelligence for Medical Image Processing at the University of Technology of Belfort Montbeliard, France. With two documented research documents and an identified ORCID record, the profile represents an emerging scholarly contribution within a field where artificial intelligence and medical imaging increasingly intersect. The Innovative Research Award provides a suitable recognition framework for evaluating such work, subject to verification of the complete research record and formal award criteria.

References

  1. Ronneberger, O., Fischer, P., & Brox, T. (2015). U-Net: Convolutional networks for biomedical image segmentation. Medical Image Computing and Computer-Assisted Intervention (MICCAI), 234–241.
    https://doi.org/10.1007/978-3-319-24574-4_28
  2. Kelly, C. J., Karthikesalingam, A., Suleyman, M., Corrado, G., & King, D. (2019). Key challenges for delivering clinical impact with artificial intelligence. BMC Medicine, 17, 195.
    https://doi.org/10.1186/s12916-019-1426-2
  3. ORCID. (n.d.). ORCID record: Halima Fouadi, ORCID iD 0009-0003-0733-9832. ORCID.
    https://orcid.org/0009-0003-0733-9832
  4. International Research Awards on Network Science & Graph Analytics. (n.d.). Award Website.
    https://networkscience-conferences.researchw.com/

Winston Dunn | Artificial Intelligence |  Best Researcher Award

Dr. Winston Dunn | Artificial Intelligence |  Best Researcher Award

The University Of Kansas Medical Center | United States

Author Profiles

Scopus

Orcid ID

Early Academic Pursuits

Dr. Winston Dunn began his academic journey with a Bachelor of Science in Biochemistry from the University of British Columbia. He pursued his medical degree at Ross University School of Medicine and later completed advanced training at The Chicago Medical School. His strong foundation in internal medicine was built through residency at the Mayo Graduate School of Medicine, followed by specialized fellowships in Gastroenterology at the University of California, San Diego, and in Transplant Hepatology at Mayo Clinic. Parallel to his clinical training, he enriched his expertise with a Master’s in Public Health, highlighting his commitment to blending clinical practice with population health perspectives.

Professional Endeavors

Dr. Dunn’s academic career began as an Instructor in Medicine at the Mayo Clinic College of Medicine (2009–2010). He then joined the University of Kansas Medical Center as an Assistant Professor (2010–2016), rising to Associate Professor (2016–2025), and currently serves as Professor in the Division of Gastroenterology. His steady progression reflects consistent excellence in teaching, research, and clinical leadership. Additionally, his professional licensure across multiple states and board certifications in Internal Medicine, Gastroenterology, and Transplant Hepatology highlight his depth of expertise.

Contributions and Research Focus

Dr. Dunn’s research is primarily centered on liver diseases, with a special focus on nonalcoholic steatohepatitis (NASH), metabolic dysfunction-associated steatohepatitis (MASH), cirrhosis, and outcomes after hepatitis C treatment. He has been the principal investigator in numerous Phase II and Phase III clinical trials, collaborating with leading pharmaceutical companies and institutions. His studies explore genetic predictors of liver disease outcomes, non-invasive biomarkers, and novel therapeutics aimed at reversing fibrosis and improving survival. He also contributed to improving models of care, diagnosis, and patient referral systems in hepatology.

Impact and Influence

Dr. Dunn’s work has had significant clinical implications, advancing knowledge in liver transplantation, NASH therapeutics, and hepatology practice. His role in high-impact trials, including those supported by Gilead Sciences, Novo Nordisk, and Madrigal Pharmaceuticals, positions him as a leader in shaping the future of liver disease management. His active service on the AASLD Alcoholic Liver Disease Steering Committee and Education Subcommittee further demonstrates his influence on clinical guidelines, education, and policy within the hepatology community.

Academic Citations and Recognition

Dr. Dunn’s contributions have been recognized through multiple awards, including the Sheila Sherlock Clinical and Translational Research Award (2012), the AASLD Advanced Transplant Hepatology Fellowship Award (2009), and induction as a Fellow of the American Association for the Study of Liver Diseases (FAASLD) in 2023. His research has generated numerous publications and citations, reflecting his impact on both scientific literature and clinical practice.

Legacy and Future Contributions

With an established record of academic excellence, groundbreaking research, and mentorship, Dr. Dunn’s legacy lies in advancing hepatology through both innovative research and translational impact. His ongoing leadership in pivotal trials will likely redefine therapeutic standards for NASH and related liver conditions. As a Professor at the University of Kansas Medical Center, he is poised to continue mentoring future hepatologists while contributing to international collaborations that influence the global fight against liver disease.

Conclusion

In summary, Dr. Winston Dunn exemplifies the qualities of a distinguished academic physician-scientist. His rigorous training, progressive academic career, and pioneering research in hepatology underscore his suitability for honors such as the Best Researcher Award. With a career dedicated to bridging clinical care, research innovation, and education, Dr. Dunn stands as a role model whose work continues to shape the future of liver disease management and patient outcomes worldwide.

Notable Publications

“Artificial Intelligence for Predictive Diagnostics, Prognosis, and Decision Support in MASLD, Hepatocellular Carcinoma, and Digital Pathology

  • Author: Nicholas Dunn; Nipun Verma; Winston Dunn
  • Journal: Journal of Clinical and Experimental Hepatology
  • Year: 2025

"Prevalence and Predictors of Suspected Metabolic Dysfunction‐Associated Steatotic Liver Disease in Adolescents in the United States

  • Author: Sheila L. Noon; Lauren F. Chun; Tin Bo Nicholas Lam; Nhat Quang N. Thai; Winston Dunn; Jeffrey B. Schwimmer‏
  • Journal: Alimentary Pharmacology & Therapeutics
  • Year: 2025

"Comparison Between Dynamic Models for Predicting Response to Corticosteroids in Alcohol‐Associated Hepatitis: A Global Cohort Study

  • Author: Francisco Idalsoaga; Luis Antonio Díaz; Leonardo Guizzetti; Winston Dunn; Heer Mehta; Jorge Arnold; Gustavo Ayares; Rokhsana Mortuza; Gurpreet Mahli; Alvi H. Islam et al.
  • Journal: Alimentary Pharmacology & Therapeutics
  • Year: 2025

"Moderate alcohol-associated hepatitis: A real-world multicenter study

  • Author: Francisco Idalsoaga; Luis Antonio Díaz; Winston Dunn; Heer Mehta; Karen Muñoz; Vicente Caldentey; Jorge Arnold; Gustavo Ayares; Rokhsana Mortuza; Shiv K. Sarin et al.
  • Journal: Hepatology Communications
  • Year: 2025

"An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study

  • Author: Winston Dunn; Yanming Li; Ashwani K. Singal; Douglas A. Simonetto; Luis A. Díaz; Francisco Idalsoaga; Gustavo Ayares; Jorge Arnold; María Ayala-Valverde; Diego Perez et al.
  • Journal: Hepatology
  • Year: 2024